BRIEF-GlycoMimetics posts Q3 loss of $0.34/share

* GlycoMimetics reports third quarter 2016 results and progress in clinical development
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.